Reglan is a pharmaceutical drug used to combat heartburn and slow gastric emptying in diabetes patients. The question is whether tardive dyskinesia (also known as TD), a neurological disorder with symptoms including repeated involuntary movements, is connected to Reglan use.
Below is a question and answer for about the Reglan lawsuits. This will read a little odd in places because much of it was written thirteen years ago. But it has 2022 additions as well, including a discussion of the possibility of a new Reglan lawsuit over the undisclosed stroke risk.









